University of South Florida team conducts trial for HIV vaccine

Tampa, FL (May 14, 2002) The University of South Florida College of Medicine has begun the human trial for a new experimental HIV vaccine at the Tampa General Hospital Clinical Research Center.

The national study, sponsored by Merck & Co., will assess the vaccine's safety and ability to produce immunity in healthy, uninfected adult volunteers. If successful, the small preliminary study would pave the way for a larger study of the vaccine's effectiveness in people at high risk for HIV infection.

"Of all the potential vaccines studied over the last 20 years, this is one of the most promising to move forward as a candidate for prevention of HIV disease," Jeffrey Nadler, MD, professor of medicine and principal investigator for the HIV vaccine trial in Tampa.

This is the first time that all three components of Merck's HIV vaccine using a prime boost regimen will be tested in humans.

USF/TGH is one of two research centers in Florida and 16 nationwide involved in the placebo-controlled clinical trial. Merck expects to enroll 126 people nationwide in the 18-month clinical trial, including 10 at TGH.

Traditionally, vaccines, such as the polio vaccine, work by encouraging antibodies to prevent infection. However, most vaccines designed to stimulate production of antibodies against HIV have not worked well because the cryptic virus changes itself slightly to evade attack.

Instead of building antibodies, this new HIV vaccine boosts the activity of killer cells in the immune system, called T-lymphocytes, to target and kill the cells containing HIV. "The challenge is to stimulate very specific responses that are directed at the HIV itself" without destroying healthy immune cells, Dr. Nadler said.

Earlier this year, Merck announced that the vaccine sharply slowed the reproduction of the AIDS virus in laboratory monkeys that became infected with HIV. In contrast, most unvaccinated monkeys died or developed AIDS. In addi

Contact: Anne DeLotto Baier
University of South Florida Health

Page: 1 2

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:

(Date:3/26/2019)... WORTH, Texas (PRWEB) , ... March 26, 2019 ... ... plans to achieve corporate objectives for the company’s products and services. In her ... on lifecyclebio.com, maintain and further develop the company’s website and customer beneficial features ...
(Date:3/23/2019)... ... March 21, 2019 , ... Artificial Intelligence (AI) ... particular focus on machine learning. Machine learning is a branch of AI focused ... or ‘training’. Through machine learning, scientists are able to build predictive models and ...
(Date:3/18/2019)... ... March 18, 2019 , ... ... the microbiome industry and the third highest quality portfolio following Seres Health and ... Manuel Fankhauser, Christian Moser, and Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... , ... March 19, 2019 , ... Bogey was nine years old when he injured ... his left hip. These ailments caused Bogey to experience problems with his mobility. ... stairs, and onto his special spot on the couch. , His owners, devastated at the ...
(Date:3/19/2019)... (PRWEB) , ... March 19, 2019 , ... This free webinar will review ... , Learn how to reduce study build times by up to 30 percent, ... a cloud platform enables mid-study changes without the need to migrate data – reducing risk ...
(Date:3/19/2019)... ... March 19, 2019 , ... ... cloud solutions, today announced it has begun offering NVIDIA® DGX-1™ deep learning systems ... utilize DGX-1, designed to provide the highest performance for artificial intelligence and deep ...
(Date:3/15/2019)... ... March 15, 2019 , ... ... American Process Inc. and affiliate companies including AVAPCO LLC and API Intellectual ... the Thomaston Biorefinery and R&D center in Thomaston, Georgia, operations, research, and ...
Breaking Biology Technology:
Cached News: